Article

Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351

2021-04-12

Abstract excerpt

The pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. During the years of 2020-2021, millions of humans have died due to SARS-CoV-2 infection and severe economic damage to the global economy has occurred. Unprecedented rapid investments in vaccine development have been made to counter the spread of SARS-CoV-2 among humans. While vaccines are a key pillar of moder...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 24ad550d-1ef8-526f-81fb-d50d1f9202c9
DOI: 10.1101/2021.04.11.439360

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351DOI 10.1101/2021.04.11.439360Read

An alpaca-derived nanobody recognizes a unique conserved epitope and retains potent activity against the SARS-CoV-2 omicron variantSemantic proximity Read

Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variantsSemantic proximity Read

Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.Semantic proximity Read

Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding DomainSemantic proximity Read

Superimmunity by pan-sarbecovirus nanobodiesSemantic proximity Read

Broad Neutralizing Antibodies Against SARS-CoV-2: Current Progress and Engineering Strategies.Semantic proximity Read

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.Semantic proximity Read

An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variantsSemantic proximity Read

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variantsSemantic proximity Read

Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virusSemantic proximity Read

Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variantsSemantic proximity Read

Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecovirusesSemantic proximity Read